tranexamic acid has been researched along with Gastrointestinal Hemorrhage in 98 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Gastrointestinal Hemorrhage: Bleeding in any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Tranexamic acid (TXA) is an antifibrinolytic agent used to control bleeding in different circumstances." | 6.94 | A randomized controlled trial of the effects of local tranexamic acid on mortality, rebleeding, and recurrent endoscopy need in patients with upper gastrointestinal hemorrhage. ( Doğan, NÖ; Karadaş, A; Pekdemir, M; Pinar, SG; Yaka, E; Yeşil, O; Yilmaz, S, 2020) |
| "The current therapeutic strategy for disseminated intravascular coagulation (DIC) is limited to control of the underlying disease, and methods for the effective management of DIC have not been established." | 5.34 | Successful combined use of tranexamic acid and unfractionated heparin for life-threatening bleeding associated with intravascular coagulation in a patient with chronic myelogenous leukemia in blast crisis. ( Asada, N; Asakura, H; Koseki, M; Matsue, K; Takeuchi, M; Uryu, H, 2007) |
| "Colonic angiodysplasias are a common source of gastrointestinal bleeding in patients with end-stage renal disease (ESRD)." | 5.30 | Successful treatment of bleeding from colonic angiodysplasias with tranexamic acid in a hemodialysis patient. ( Lavre, J; Sabovic, M; Vujkovac, B, 1998) |
| "Tranexamic acid appears to be a reasonable adjunct for the emergency medicine clinician to consider in the management of many hemorrhagic conditions and angiotensin converting enzyme inhibitor-induced angioedema." | 5.22 | Tranexamic acid - A narrative review for the emergency medicine clinician. ( Santiago, R; Wang, K, 2022) |
| "We studied the effects of tranexamic acid (an antifibrinolytic agent) and cimetidine on acute upper-gastrointestinal-tract bleeding in a double-blind randomized placebo-controlled trial in 775 patients with hematemesis or melena or both." | 5.05 | Cimetidine and tranexamic acid in the treatment of acute upper-gastrointestinal-tract bleeding. ( Atkinson, M; Barer, D; Coggon, D; Dronfield, M; Ellis, S; French, S; Henry, D; Langman, M; Ogilvie, A, 1983) |
| "The effect or oral tranexamic acid on massive upper gastrointestinal hemorrhage was evaluated in a randomized double-blind study." | 5.05 | Local inhibition of the fibrinolytic system in patients with massive upper gastrointestinal hemorrhage. ( Bergqvist, D; Dahlgren, S; Hessman, Y, 1980) |
| "To report a case of toxic epidermal necrolysis (TEN) induced by orally administered tranexamic acid in a patient with liver cirrhosis and acute rectal bleeding." | 3.79 | Tranexamic acid-induced toxic epidermal necrolysis. ( Aguado Gil, L; Idoate Gastearena, MA; Marques Martin, L; Pretel Irazabal, M, 2013) |
| " prevented formation of ulcers induced by serotonin, indomethacin, acetylsalicylic acid or stress (acute ulcer models), its effect being greater against gastric ulcers induced by serotonin." | 3.67 | Anti-ulcer effect of 3-[p-(trans-4-aminomethylcyclohexylcarbonyl) phenyl] propionic acid hydrochloride (TEI-5103). ( Hoshina, K; Naruchi, T; Takeshita, T; Yamazaki, N, 1985) |
| "Tranexamic acid (TXA) is a common haemorrhage control agent in both emergency department (ED) settings and intra-operatively." | 3.01 | Tranexamic acid in emergency medicine. An overview of reviews. ( Dhingra, P; Lang, E; Yeung, M, 2023) |
| "Tranexamic acid (TXA) is an antifibrinolytic agent used to control bleeding in different circumstances." | 2.94 | A randomized controlled trial of the effects of local tranexamic acid on mortality, rebleeding, and recurrent endoscopy need in patients with upper gastrointestinal hemorrhage. ( Doğan, NÖ; Karadaş, A; Pekdemir, M; Pinar, SG; Yaka, E; Yeşil, O; Yilmaz, S, 2020) |
| "Venous thromboembolic events (deep vein thrombosis or pulmonary embolism) were higher in tranexamic acid group than in the placebo group (48 [0·8%] of 5952 vs 26 [0·4%] of 5977; RR 1·85; 95% CI 1·15 to 2·98)." | 2.94 | Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial. ( , 2020) |
| "Tranexamic acid is an antifibrinolytic that has been shown to reduce blood loss in a variety of clinical conditions." | 2.87 | Tranexamic Acid for Lower GI Hemorrhage: A Randomized Placebo-Controlled Clinical Trial. ( Bendinelli, C; Carroll, R; Draganic, BD; Murray, D; Pockney, PG; Smith, SR, 2018) |
| "Studies were analyzed as high-dose IV tranexamic acid versus all other dosing strategies for tranexamic acid using fixed-effects models." | 2.82 | Tranexamic Acid in Gastrointestinal Bleeding: A Systematic Review and Meta-Analysis. ( Antonelli, M; Dionne, JC; Hunt, BJ; Oczkowski, SJW; Raasveld, SJ; Vlaar, APJ; Wijnberge, M, 2022) |
| "Tranexamic acid has been shown to reduce the need for blood transfusion in surgical patients and to reduce mortality in bleeding trauma patients, with no apparent increase in thromboembolic events." | 2.79 | HALT-IT--tranexamic acid for the treatment of gastrointestinal bleeding: study protocol for a randomised controlled trial. ( Coats, T; Edwards, P; Gilmore, I; Jairath, V; Ker, K; Manno, D; Roberts, I; Shakur, H; Stanworth, S; Veitch, A, 2014) |
| " In 16 episodes of bleeding TXA was used (in a dosage of 20 mg intravenously, followed for the next 4 weeks by 10 mg/kg/48 h orally), whereas in 20 other cases of bleeding, TXA was not used." | 2.71 | Tranexamic acid is beneficial as adjunctive therapy in treating major upper gastrointestinal bleeding in dialysis patients. ( Lavre, J; Sabovic, M; Vujkovac, B, 2003) |
| "Treatment with tranexamic acid was associated with a 20-30% reduction in the rate of rebleeding, a 30-40% reduction (95% confidence interval 10% to 60%) in mortality." | 2.66 | Effects of fibrinolytic inhibitors on mortality from upper gastrointestinal haemorrhage. ( Henry, DA; O'Connell, DL, 1989) |
| " Therefore, thromboembolic risk and tranexamic acid dosage should be carefully evaluated." | 2.53 | [Tranexamic acid for upper gastrointestinal bleeding]. ( Fenger-Eriksen, C; Jessing, TD, 2016) |
| "The current therapeutic strategy for disseminated intravascular coagulation (DIC) is limited to control of the underlying disease, and methods for the effective management of DIC have not been established." | 1.34 | Successful combined use of tranexamic acid and unfractionated heparin for life-threatening bleeding associated with intravascular coagulation in a patient with chronic myelogenous leukemia in blast crisis. ( Asada, N; Asakura, H; Koseki, M; Matsue, K; Takeuchi, M; Uryu, H, 2007) |
| "A patient with von Willebrand's disease had recurrent gastrointestinal bleeding from angiodysplasia, with inadequate response to von Willebrand factor substitution, medical and endoscopic treatment, and resection of affected bowel." | 1.31 | Recurrent severe bleeding from gastrointestinal angiodysplasia in a patient with von Willebrand's disease, controlled with recombinant factor VIIa. ( Meijer, K; Peters, FT; van der Meer, J, 2001) |
| "Colonic angiodysplasias are a common source of gastrointestinal bleeding in patients with end-stage renal disease (ESRD)." | 1.30 | Successful treatment of bleeding from colonic angiodysplasias with tranexamic acid in a hemodialysis patient. ( Lavre, J; Sabovic, M; Vujkovac, B, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (21.43) | 18.7374 |
| 1990's | 7 (7.14) | 18.2507 |
| 2000's | 12 (12.24) | 29.6817 |
| 2010's | 27 (27.55) | 24.3611 |
| 2020's | 31 (31.63) | 2.80 |
| Authors | Studies |
|---|---|
| Roberts, I | 8 |
| Shakur-Still, H | 3 |
| Afolabi, A | 2 |
| Akere, A | 1 |
| Arribas, M | 3 |
| Austin, E | 1 |
| Bal, K | 1 |
| Bazeer, N | 1 |
| Beaumont, D | 2 |
| Brenner, A | 2 |
| Carrington, L | 1 |
| Chaudhri, R | 2 |
| Coats, T | 4 |
| Gilmore, I | 4 |
| Halligan, K | 1 |
| Hussain, I | 1 |
| Jairath, V | 4 |
| Javaid, K | 2 |
| Kayani, A | 2 |
| Lisman, T | 1 |
| Mansukhani, R | 2 |
| Miners, A | 1 |
| Mutti, M | 2 |
| Nadeem, MA | 2 |
| Pollok, R | 1 |
| Prowse, D | 1 |
| Simmons, J | 1 |
| Stanworth, S | 3 |
| Veitch, A | 4 |
| Williams, J | 1 |
| Dionne, JC | 1 |
| Oczkowski, SJW | 1 |
| Hunt, BJ | 1 |
| Antonelli, M | 1 |
| Wijnberge, M | 1 |
| Raasveld, SJ | 1 |
| Vlaar, APJ | 1 |
| Fong, MW | 1 |
| Morningstar-Kywi, N | 1 |
| O'Connell, C | 1 |
| Qureshi, U | 1 |
| Han, EE | 1 |
| Wang, K | 1 |
| Santiago, R | 1 |
| Tran, QK | 1 |
| Tang, K | 1 |
| Pourmand, A | 1 |
| Tsai, HW | 2 |
| Lee, PL | 4 |
| Kang, YN | 5 |
| Grocott, MPW | 2 |
| Murphy, M | 2 |
| Sayers, R | 2 |
| Toh, CH | 2 |
| Dhingra, P | 1 |
| Yeung, M | 1 |
| Lang, E | 1 |
| Ker, K | 3 |
| Fujimori, S | 1 |
| Ochoco, GETD | 1 |
| Enriquez, CAG | 1 |
| Urgel, RJL | 1 |
| Catibog, JS | 1 |
| Karadaş, A | 1 |
| Doğan, NÖ | 1 |
| Pinar, SG | 1 |
| Yeşil, O | 1 |
| Pekdemir, M | 1 |
| Yilmaz, S | 1 |
| Yaka, E | 1 |
| Stanworth, SJ | 2 |
| Twum-Barimah, E | 1 |
| Abdelgadir, I | 1 |
| Gordon, M | 1 |
| Akobeng, AK | 1 |
| Perner, A | 1 |
| Møller, MH | 1 |
| Dorgalaleh, A | 1 |
| Baghaipour, MR | 1 |
| Tabibian, S | 1 |
| Ghazizadeh, F | 1 |
| Dabbagh, A | 1 |
| Bahoush, G | 1 |
| Jazebi, M | 1 |
| Bahraini, M | 1 |
| Fazeli, A | 1 |
| Baghaipour, N | 1 |
| Yousefi, F | 1 |
| Roberts, LN | 1 |
| Miyamoto, Y | 1 |
| Ohbe, H | 1 |
| Ishimaru, M | 1 |
| Matsui, H | 1 |
| Fushimi, K | 1 |
| Yasunaga, H | 1 |
| Gilbert, BW | 1 |
| Rech, MA | 1 |
| Yang, KS | 1 |
| Hou, SK | 1 |
| Chang, CC | 2 |
| Horton, LC | 1 |
| Feuerstein, JD | 1 |
| Erasu, V | 1 |
| Novak, A | 1 |
| Kamal, F | 1 |
| Khan, MA | 1 |
| Lee-Smith, W | 1 |
| Sharma, S | 1 |
| Imam, Z | 1 |
| Jowhar, D | 1 |
| Petryna, E | 1 |
| Marella, HK | 1 |
| Aksionav, P | 1 |
| Iqbal, U | 1 |
| Tombazzi, C | 1 |
| Howden, CW | 1 |
| Suk, FM | 1 |
| Al-Samkari, H | 1 |
| Ho, YW | 1 |
| Chang, CY | 1 |
| Huang, HK | 1 |
| Chen, YL | 1 |
| Wu, MY | 1 |
| Polsky, Z | 1 |
| Damji, O | 1 |
| Bond, C | 1 |
| Ma, C | 1 |
| Lin, YC | 1 |
| Chen, CY | 1 |
| Murata, M | 1 |
| Bamba, S | 1 |
| Takahashi, K | 1 |
| Imaeda, H | 1 |
| Nishida, A | 1 |
| Inatomi, O | 1 |
| Tsujikawa, T | 1 |
| Kushima, R | 1 |
| Sugimoto, M | 1 |
| Andoh, A | 1 |
| Stollings, JL | 1 |
| Landsperger, JS | 1 |
| Semler, MW | 1 |
| Rice, TW | 1 |
| Grooteman, KV | 1 |
| van Geenen, EJM | 1 |
| Drenth, JPH | 1 |
| Smith, SR | 1 |
| Murray, D | 1 |
| Pockney, PG | 1 |
| Bendinelli, C | 1 |
| Draganic, BD | 1 |
| Carroll, R | 1 |
| Sepulveda, A | 1 |
| Soriano, H | 1 |
| Espino, A | 1 |
| Heidet, M | 1 |
| Amathieu, R | 1 |
| Audureau, E | 1 |
| Augusto, O | 1 |
| Nicolazo de Barmon, V | 1 |
| Rialland, A | 1 |
| Schmitz, D | 1 |
| Pierrang, F | 1 |
| Marty, J | 1 |
| Chollet-Xémard, C | 1 |
| Thirion, O | 1 |
| Jacob, L | 1 |
| Altawil, Z | 1 |
| Gendron, BJ | 1 |
| Schechter-Perkins, EM | 1 |
| Cotzias, E | 1 |
| Rehman, SF | 1 |
| Arsalani Zadeh, R | 1 |
| Smith, D | 1 |
| Ahmad, SM | 1 |
| Cuzick, J | 1 |
| Hawkey, C | 1 |
| Pretel Irazabal, M | 1 |
| Marques Martin, L | 1 |
| Aguado Gil, L | 1 |
| Idoate Gastearena, MA | 1 |
| Otrock, ZK | 1 |
| Degheili, JA | 1 |
| Sibai, H | 1 |
| Salem, ZM | 1 |
| Cho, SH | 1 |
| Kim, SW | 1 |
| Kim, WC | 1 |
| Chul-Hyun, L | 1 |
| Go, BS | 1 |
| Manno, D | 3 |
| Fischer, Q | 1 |
| Huisse, MG | 1 |
| Voiriot, G | 1 |
| Caron, C | 1 |
| Lepage, L | 1 |
| Dilly, MP | 1 |
| Nataf, P | 1 |
| Ajzenberg, N | 1 |
| Kirsch, M | 1 |
| Edwards, P | 2 |
| Shakur, H | 2 |
| Bennett, C | 1 |
| Klingenberg, SL | 3 |
| Langholz, E | 2 |
| Gluud, LL | 4 |
| Bilkhu, A | 1 |
| Saha, A | 1 |
| Ilsley, DW | 1 |
| Atikah, N | 1 |
| Singh, G | 1 |
| Maulahela, H | 1 |
| Cahyanur, R | 1 |
| Flores, S | 1 |
| Avilés, C | 1 |
| Rada, G | 1 |
| Tutchenko, MI | 1 |
| Rudyk, DV | 1 |
| Iskra, NI | 1 |
| Trofimenko, SP | 1 |
| Shchur, IV | 1 |
| Jessing, TD | 1 |
| Fenger-Eriksen, C | 1 |
| Hu, D | 1 |
| Miliam, PB | 1 |
| Carron, M | 1 |
| Globokar, P | 1 |
| Sicard, BA | 1 |
| Hansen, LF | 1 |
| Wewer, V | 1 |
| Pedersen, SA | 1 |
| Matzen, P | 1 |
| Paerregaard, A | 1 |
| Kovacs, TO | 1 |
| Jensen, DM | 1 |
| Almadi, M | 1 |
| Ghali, PM | 1 |
| Constantin, A | 1 |
| Galipeau, J | 1 |
| Szilagyi, A | 1 |
| Yadav, SP | 1 |
| Sachdeva, A | 1 |
| Bhat, S | 1 |
| Katewa, S | 1 |
| Sabovic, M | 2 |
| Lavre, J | 2 |
| Vujkovac, B | 2 |
| Amarapurkar, DN | 1 |
| Patel, ND | 1 |
| Stovicek, J | 1 |
| Keil, R | 1 |
| Pálová, S | 1 |
| Lochmannová, J | 1 |
| Koseki, M | 1 |
| Asada, N | 1 |
| Uryu, H | 1 |
| Takeuchi, M | 1 |
| Asakura, H | 1 |
| Matsue, K | 1 |
| Langholz, SE | 1 |
| Barer, D | 2 |
| Ogilvie, A | 1 |
| Henry, D | 1 |
| Dronfield, M | 1 |
| Coggon, D | 1 |
| French, S | 1 |
| Ellis, S | 1 |
| Atkinson, M | 1 |
| Langman, M | 1 |
| Chalmers, TC | 1 |
| Low, J | 1 |
| Dodds, AJ | 2 |
| Biggs, JC | 2 |
| Hollanders, D | 1 |
| Thomson, JM | 1 |
| Schofield, PF | 1 |
| Poller, L | 1 |
| Bergqvist, D | 1 |
| Dahlgren, S | 1 |
| Hessman, Y | 1 |
| Patchett, SE | 1 |
| O'Donoghue, DP | 1 |
| de Pont, AC | 1 |
| Zandstra, DF | 1 |
| Katsaros, D | 1 |
| Grundfest-Broniatowski, S | 1 |
| McCormick, PA | 1 |
| Ooi, H | 1 |
| Crosbie, O | 1 |
| Baerlocher, GM | 1 |
| Leoncini-Franscini, L | 1 |
| Wuillemin, WA | 1 |
| Furlan, M | 1 |
| Meijer, K | 1 |
| Peters, FT | 1 |
| van der Meer, J | 1 |
| Hawkey, GM | 1 |
| Cole, AT | 1 |
| McIntyre, AS | 1 |
| Long, RG | 1 |
| Hawkey, CJ | 1 |
| Burak, KW | 1 |
| Lee, SS | 1 |
| Beck, PL | 1 |
| MacLean, JE | 1 |
| Cohen, E | 1 |
| Weinstein, M | 1 |
| Nilsson, IM | 2 |
| Bergentz, SE | 1 |
| Hedner, U | 1 |
| Kullenberg, K | 1 |
| Ostberg, HO | 1 |
| Ulfberg, J | 1 |
| Wennerholm, M | 1 |
| Zellner, K | 1 |
| Engqvist, A | 1 |
| Broström, O | 1 |
| von Feilitzen, F | 1 |
| Halldin, M | 1 |
| Nyström, B | 1 |
| Ost, A | 1 |
| Reichard, H | 1 |
| Sandqvist, S | 1 |
| Törngren, S | 1 |
| Wedlund, JE | 1 |
| Hugh, TB | 1 |
| Prentice, CR | 1 |
| Henry, DA | 1 |
| O'Connell, DL | 1 |
| Langman, MJ | 1 |
| von Holstein, CC | 2 |
| Eriksson, SB | 2 |
| Källén, R | 2 |
| Berstad, A | 1 |
| Almodovar, K | 1 |
| Berstad, K | 1 |
| Anderson, W | 1 |
| Hirschowitz, BI | 1 |
| Isacson, S | 1 |
| Hoshina, K | 1 |
| Yamazaki, N | 1 |
| Takeshita, T | 1 |
| Naruchi, T | 1 |
| Navab, F | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Tranexamic Acid for the Treatment of Gastrointestinal Haemorrhage: an International Randomised, Double Blind Placebo Controlled Trial[NCT01658124] | Phase 3 | 12,009 participants (Actual) | Interventional | 2013-07-31 | Completed | ||
| Precise Application of Topical Tranexamic Acid to Enhance Endoscopic Hemostasis for Peptic Ulcer Bleeding: A Randomized Controlled Study[NCT05248321] | 60 participants (Actual) | Interventional | 2022-03-24 | Completed | |||
| Tranexamic Acid to Prevent Bleeding After Endoscopic Resection of Large Colorectal Polyps: A Pilot Project[NCT04559880] | Phase 4 | 25 participants (Actual) | Interventional | 2020-09-10 | Active, not recruiting | ||
| Efficacy and Safety of Early Administration of Tranexamic Acid in Cirrhotic Patients Presenting With Acute Upper Gastrointestinal Bleeding: a Multicenter, Randomized, Double Blind, Placebo-controlled Trial (Modified by amendment1)[NCT03023189] | Phase 4 | 500 participants (Anticipated) | Interventional | 2017-04-03 | Recruiting | ||
| Pilot RCT: Use of Tranexamic Acid (TXA) in Post Mastectomy Patients for Seroma and Hematoma Prevention[NCT03738527] | Phase 4 | 100 participants (Anticipated) | Interventional | 2019-10-07 | Recruiting | ||
| The Role of Tranexamic Acid for the Treatment of Gastrointestinal Bleeding: A Randomized Double-blind Controlled Trial[NCT03540368] | 336 participants (Anticipated) | Interventional | 2018-07-04 | Suspended (stopped due to increased number of patients death) | |||
| Local Administration of Tranexamic Acid in Upper Gastrointestinal Hemorrhage: A Double-Blind, Randomized, Placebo-Controlled Trial[NCT02903017] | Phase 4 | 114 participants (Actual) | Interventional | 2016-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
23 reviews available for tranexamic acid and Gastrointestinal Hemorrhage
| Article | Year |
|---|---|
Tranexamic Acid in Gastrointestinal Bleeding: A Systematic Review and Meta-Analysis.
Topics: Antifibrinolytic Agents; Gastrointestinal Hemorrhage; Humans; Length of Stay; Secondary Prevention; | 2022 |
Tranexamic acid - A narrative review for the emergency medicine clinician.
Topics: Angioedema; Antifibrinolytic Agents; Emergency Medicine; Gastrointestinal Hemorrhage; Humans; Tranex | 2022 |
Tranexamic acid and Gastrointestinal bleed: Effect of the HALT-IT trial on current meta-analysis.
Topics: Antifibrinolytic Agents; Clinical Trials as Topic; Gastrointestinal Hemorrhage; Humans; Tranexamic A | 2022 |
Tranexamic acid in emergency medicine. An overview of reviews.
Topics: Antifibrinolytic Agents; Emergency Medicine; Gastrointestinal Hemorrhage; Humans; Subarachnoid Hemor | 2023 |
Tranexamic acid for gastrointestinal bleeding: can a reduction in the risk of death be discounted? A systematic review and meta-analysis of individual patient data from 64 724 bleeding patients.
Topics: Antifibrinolytic Agents; Female; Gastrointestinal Hemorrhage; Humans; Pregnancy; Tranexamic Acid; Va | 2023 |
Tranexamic acid may be a useful pharmacotherapy for endoscopically resistant small bowel angiodysplasia.
Topics: Angiodysplasia; Colonic Diseases; Gastrointestinal Hemorrhage; Humans; Telangiectasia, Hereditary He | 2023 |
Systematic review with meta-analysis: the efficacy of tranexamic acid in upper gastrointestinal bleeding.
Topics: Antifibrinolytic Agents; Blood Transfusion; Controlled Clinical Trials as Topic; Female; Gastrointes | 2020 |
Tranexamic acid for gastrointestinal bleeding: A systematic review with meta-analysis of randomized clinical trials.
Topics: Antifibrinolytic Agents; Gastrointestinal Hemorrhage; Humans; Randomized Controlled Trials as Topic; | 2021 |
Efficacy and safety of tranexamic acid in acute upper gastrointestinal bleeding: meta-analysis of randomised controlled trials.
Topics: Blood Transfusion; Gastrointestinal Hemorrhage; Humans; Tranexamic Acid | 2020 |
Hereditary hemorrhagic telangiectasia: systemic therapies, guidelines, and an evolving standard of care.
Topics: Anemia; Angiogenesis Inhibitors; Anticoagulants; Antifibrinolytic Agents; Clinical Trials as Topic; | 2021 |
How effective is tranexamic acid for acute gastrointestinal bleeding?
Topics: Acute Disease; Antifibrinolytic Agents; Gastrointestinal Hemorrhage; Humans; Injections, Intravenous | 2014 |
Tranexamic acid for upper gastrointestinal bleeding.
Topics: Administration, Oral; Aluminum Hydroxide; Anti-Ulcer Agents; Antifibrinolytic Agents; Cimetidine; Dr | 2014 |
Tranexamic acid for upper gastrointestinal bleeding.
Topics: Administration, Oral; Aluminum Hydroxide; Anti-Ulcer Agents; Antifibrinolytic Agents; Cimetidine; Dr | 2014 |
Tranexamic acid for upper gastrointestinal bleeding.
Topics: Administration, Oral; Aluminum Hydroxide; Anti-Ulcer Agents; Antifibrinolytic Agents; Cimetidine; Dr | 2014 |
Tranexamic acid for upper gastrointestinal bleeding.
Topics: Administration, Oral; Aluminum Hydroxide; Anti-Ulcer Agents; Antifibrinolytic Agents; Cimetidine; Dr | 2014 |
Tranexamic acid for upper gastrointestinal bleeding.
Topics: Administration, Oral; Aluminum Hydroxide; Anti-Ulcer Agents; Antifibrinolytic Agents; Cimetidine; Dr | 2014 |
Tranexamic acid for upper gastrointestinal bleeding.
Topics: Administration, Oral; Aluminum Hydroxide; Anti-Ulcer Agents; Antifibrinolytic Agents; Cimetidine; Dr | 2014 |
Tranexamic acid for upper gastrointestinal bleeding.
Topics: Administration, Oral; Aluminum Hydroxide; Anti-Ulcer Agents; Antifibrinolytic Agents; Cimetidine; Dr | 2014 |
Tranexamic acid for upper gastrointestinal bleeding.
Topics: Administration, Oral; Aluminum Hydroxide; Anti-Ulcer Agents; Antifibrinolytic Agents; Cimetidine; Dr | 2014 |
Tranexamic acid for upper gastrointestinal bleeding.
Topics: Administration, Oral; Aluminum Hydroxide; Anti-Ulcer Agents; Antifibrinolytic Agents; Cimetidine; Dr | 2014 |
Extending evidence for the use of tranexamic acid from traumatic haemorrhage to other patients with major bleeding: do we need more than one haemorrhage protocol? The case of gastrointestinal bleeding.
Topics: Adult; Clinical Trials as Topic; Female; Gastrointestinal Hemorrhage; Humans; Male; Tranexamic Acid; | 2015 |
Is tranexamic acid effective for acute upper gastrointestinal bleeding?
Topics: Acute Disease; Antifibrinolytic Agents; Gastrointestinal Hemorrhage; Humans; Randomized Controlled T | 2015 |
[Tranexamic acid for upper gastrointestinal bleeding].
Topics: Antifibrinolytic Agents; Gastrointestinal Hemorrhage; Humans; Risk Factors; Thromboembolism; Tranexa | 2016 |
The short-term medical management of non-variceal upper gastrointestinal bleeding.
Topics: Animals; Gastrointestinal Hemorrhage; Histamine H2 Antagonists; Hormone Antagonists; Humans; Octreot | 2008 |
Recurrent obscure gastrointestinal bleeding: dilemmas and success with pharmacological therapies. Case series and review.
Topics: Aged; Aged, 80 and over; Angiodysplasia; Angiogenesis Inhibitors; Angiography; Animals; Antifibrinol | 2009 |
Tranexamic acid for upper gastrointestinal bleeding.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Aluminum Hydroxide; Anti-Ulcer Agents | 2012 |
Systematic review: tranexamic acid for upper gastrointestinal bleeding.
Topics: Antifibrinolytic Agents; Endoscopy, Gastrointestinal; Gastrointestinal Hemorrhage; Humans; Randomize | 2008 |
Portal hypertensive gastropathy and gastric antral vascular ectasia (GAVE) syndrome.
Topics: Adrenergic beta-Antagonists; Antifibrinolytic Agents; Diagnosis, Differential; Esophageal and Gastri | 2001 |
Local fibrinolysis as a mechanism for haemorrhage.
Topics: Aminocaproates; Endometrium; Epistaxis; Female; Fibrinolysis; Gastric Juice; Gastrointestinal Hemorr | 1975 |
Indications for antifibrinolytic therapy.
Topics: Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Coagulation Disorders; Disseminated Intrav | 1975 |
Tranexamic acid in acute upper gastrointestinal bleeding.
Topics: Blood Transfusion; Cyclohexanecarboxylic Acids; Gastrointestinal Hemorrhage; Humans; Tranexamic Acid | 1987 |
20 trials available for tranexamic acid and Gastrointestinal Hemorrhage
| Article | Year |
|---|---|
A high-dose 24-hour tranexamic acid infusion for the treatment of significant gastrointestinal bleeding: HALT-IT RCT.
Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Cost-Benefit Analysis; Gastrointestinal Hemorrhag | 2021 |
A randomized controlled trial of the effects of local tranexamic acid on mortality, rebleeding, and recurrent endoscopy need in patients with upper gastrointestinal hemorrhage.
Topics: Antifibrinolytic Agents; Double-Blind Method; Endoscopy; Gastrointestinal Hemorrhage; Humans; Tranex | 2020 |
Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial.
Topics: Acute Disease; Adult; Aged; Antifibrinolytic Agents; Case-Control Studies; Double-Blind Method; Fema | 2020 |
Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial.
Topics: Acute Disease; Adult; Aged; Antifibrinolytic Agents; Case-Control Studies; Double-Blind Method; Fema | 2020 |
Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial.
Topics: Acute Disease; Adult; Aged; Antifibrinolytic Agents; Case-Control Studies; Double-Blind Method; Fema | 2020 |
Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial.
Topics: Acute Disease; Adult; Aged; Antifibrinolytic Agents; Case-Control Studies; Double-Blind Method; Fema | 2020 |
An alternative perspective to just halting tranexamic acid utilization in gastrointestinal bleeding.
Topics: Antifibrinolytic Agents; Gastrointestinal Hemorrhage; Humans; Tranexamic Acid; Treatment Outcome | 2021 |
Tranexamic acid should be avoided for acute gastrointestinal bleeds.
Topics: Antifibrinolytic Agents; Double-Blind Method; Gastrointestinal Hemorrhage; Humans; Thromboembolism; | 2021 |
Tranexamic Acid for Lower GI Hemorrhage: A Randomized Placebo-Controlled Clinical Trial.
Topics: Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Digestive System Diseases; Double-Blind Met | 2018 |
Efficacy and tolerance of early administration of tranexamic acid in patients with cirrhosis presenting with acute upper gastrointestinal bleeding: a study protocol for a multicentre, randomised, double-blind, placebo-controlled trial (the EXARHOSE study)
Topics: Administration, Intravenous; Adult; Antifibrinolytic Agents; Double-Blind Method; France; Gastrointe | 2018 |
Tranexamic acid for acute gastrointestinal bleeding (the HALT-IT trial): statistical analysis plan for an international, randomised, double-blind, placebo-controlled trial.
Topics: Antifibrinolytic Agents; Data Interpretation, Statistical; Double-Blind Method; Gastrointestinal Hem | 2019 |
HALT-IT--tranexamic acid for the treatment of gastrointestinal bleeding: study protocol for a randomised controlled trial.
Topics: Antifibrinolytic Agents; Blood Transfusion; Clinical Protocols; Double-Blind Method; Drug Administra | 2014 |
Tranexamic acid is beneficial as adjunctive therapy in treating major upper gastrointestinal bleeding in dialysis patients.
Topics: Aged; Antifibrinolytic Agents; Combined Modality Therapy; Female; Gastrointestinal Hemorrhage; Hemos | 2003 |
Cimetidine and tranexamic acid in the treatment of acute upper-gastrointestinal-tract bleeding.
Topics: Acute Disease; Aged; Cimetidine; Clinical Trials as Topic; Cyclohexanecarboxylic Acids; Double-Blind | 1983 |
Tranexamic acid therapy in ulcerative colitis.
Topics: Adult; Aged; Colitis, Ulcerative; Cyclohexanecarboxylic Acids; Female; Gastrointestinal Hemorrhage; | 1982 |
Fibrinolysis and gastrointestinal haemorrhage.
Topics: Clinical Trials as Topic; Fibrinolysis; Gastric Mucosa; Gastrointestinal Hemorrhage; Humans; Tranexa | 1980 |
Local inhibition of the fibrinolytic system in patients with massive upper gastrointestinal hemorrhage.
Topics: Administration, Oral; Adult; Aged; Clinical Trials as Topic; Cyclohexanecarboxylic Acids; Double-Bli | 1980 |
Drug treatments in upper gastrointestinal bleeding: value of endoscopic findings as surrogate end points.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Antifibrinolytic Agents; Blood Transfusi | 2001 |
Tranexamic acid in massive haemorrhage from the upper gastrointestinal tract: a double-blind study.
Topics: Aged; Alcohol Drinking; Blood Transfusion; Clinical Trials as Topic; Cyclohexanecarboxylic Acids; Do | 1979 |
Tranexamic acid and upper gastrointestinal haemorrhage--a double-blind trial.
Topics: Adolescent; Adult; Aged; Blood Coagulation Tests; Blood Transfusion; Clinical Trials as Topic; Cyclo | 1976 |
Effects of fibrinolytic inhibitors on mortality from upper gastrointestinal haemorrhage.
Topics: Clinical Trials as Topic; Cyclohexanecarboxylic Acids; Double-Blind Method; Gastrointestinal Hemorrh | 1989 |
Tranexamic acid as an aid to reducing blood transfusion requirements in gastric and duodenal bleeding.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Transfusion; Clinical Trials as Topic; Cyclohexane | 1987 |
Tranexamic acid in gastric and duodenal bleeding.
Topics: Adult; Aged; Aged, 80 and over; Blood Transfusion; Cyclohexanecarboxylic Acids; Double-Blind Method; | 1987 |
55 other studies available for tranexamic acid and Gastrointestinal Hemorrhage
| Article | Year |
|---|---|
Tranexamic Acid in the Treatment of Refractory Gastrointestinal Arteriovenous Malformation Bleeding in Left Ventricular Assist Device Patients.
Topics: Arteriovenous Malformations; Gastrointestinal Hemorrhage; Heart Failure; Heart Ventricles; Heart-Ass | 2022 |
Is it the time to rethink how to use tranexamic acids in managing gastrointestinal bleeding?
Topics: Antifibrinolytic Agents; Gastrointestinal Hemorrhage; Humans; Tranexamic Acid | 2022 |
Tranexamic acid for safer surgery: does the evidence support preventative use? Response to Br J Anaesth 2023; 130: e23-e24.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Gastrointestinal Hemorrhage; Humans; Tranexamic Acid | 2023 |
Tranexamic acid for safer surgery: does the evidence support preventative use? Response to Br J Anaesth 2023; 130: e23-e24.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Gastrointestinal Hemorrhage; Humans; Tranexamic Acid | 2023 |
Tranexamic acid for safer surgery: does the evidence support preventative use? Response to Br J Anaesth 2023; 130: e23-e24.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Gastrointestinal Hemorrhage; Humans; Tranexamic Acid | 2023 |
Tranexamic acid for safer surgery: does the evidence support preventative use? Response to Br J Anaesth 2023; 130: e23-e24.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Gastrointestinal Hemorrhage; Humans; Tranexamic Acid | 2023 |
Multimodality imaging approach in a patient with Klippel-Trenaunay syndrome.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antifibrinolytic Agents; Endoscopy, Digestive System | 2019 |
Use of tranexamic acid in gastrointestinal bleeding and patients with haematological malignancies.
Topics: Antifibrinolytic Agents; Gastrointestinal Hemorrhage; Hematologic Neoplasms; Humans; Tranexamic Acid | 2020 |
Tranexamic acid for severe gastrointestinal bleeding.
Topics: Antifibrinolytic Agents; Double-Blind Method; Gastrointestinal Hemorrhage; Humans; Thromboembolism; | 2020 |
Gastrointestinal bleeding in a newborn infant with congenital factor X deficiency and COVID-19-A common clinical feature between a rare disorder and a new, common infection.
Topics: Betacoronavirus; Cesarean Section; Clinical Laboratory Techniques; Consanguinity; Coronavirus Infect | 2020 |
Tranexamic acid in acute gastrointestinal bleeding - A cautionary tale.
Topics: Acute Disease; Antifibrinolytic Agents; Gastrointestinal Hemorrhage; Humans; Tranexamic Acid | 2020 |
Effect of tranexamic acid in patients with colonic diverticular bleeding: A nationwide inpatient database study.
Topics: Blood Transfusion; Databases, Factual; Diverticulum, Colon; Female; Gastrointestinal Hemorrhage; Hos | 2021 |
In adults with severe acute GI bleeding, tranexamic acid did not reduce death due to bleeding at 5 days.
Topics: Adult; Antifibrinolytic Agents; Double-Blind Method; Gastrointestinal Hemorrhage; Humans; Thromboemb | 2020 |
No role for tranexamic acid in the treatment of acute gastrointestinal bleeding.
Topics: Gastrointestinal Hemorrhage; Humans; Tranexamic Acid | 2021 |
Letter: does tranexamic acid reduce the need for surgery in patients with upper gastrointestinal bleeding?
Topics: Gastrointestinal Hemorrhage; Humans; Tranexamic Acid | 2020 |
Is Tranexamic Acid for Upper Gastrointestinal Bleeding Under Debate?
Topics: Acute Disease; Antifibrinolytic Agents; Gastrointestinal Hemorrhage; Humans; Tranexamic Acid | 2021 |
Tranexamic acid for acute gastrointestinal bleeding: updated after the HALT-IT trial.
Topics: Acute Disease; Antifibrinolytic Agents; Gastrointestinal Hemorrhage; Humans; Tranexamic Acid | 2021 |
Does tranexamic acid reduce 5-day death due to bleeding in acute gastrointestinal bleed?
Topics: Acute Disease; Antifibrinolytic Agents; Gastrointestinal Hemorrhage; Humans; Tranexamic Acid | 2021 |
Letter: is there no conclusive evidence for the effect of tranexamic acid on mortality in gastrointestinal bleeding?
Topics: Antifibrinolytic Agents; Gastrointestinal Hemorrhage; Humans; Tranexamic Acid | 2021 |
Application of novel magnified single balloon enteroscopy for a patient with Cronkhite-Canada syndrome.
Topics: Aged; Antifibrinolytic Agents; Biopsy; Colonoscopy; Female; Gastrointestinal Hemorrhage; Glucocortic | 2017 |
Tranexamic acid for refractory gastrointestinal bleeds: A cohort study.
Topics: Aged; Antifibrinolytic Agents; Cohort Studies; Female; Gastrointestinal Hemorrhage; Humans; Male; Mi | 2018 |
Tranexamic acid in treatment-resistant chronic transfusion-dependent gastrointestinal angiodysplasia bleeding.
Topics: Aged; Angiodysplasia; Antifibrinolytic Agents; Erythrocyte Transfusion; Female; Gastrointestinal Hem | 2017 |
Gastrointestinal tract involvement in Klippel-Trénaunay syndrome.
Topics: Antifibrinolytic Agents; Child; Colon; Colonoscopy; Female; Gastrointestinal Hemorrhage; Humans; Kli | 2018 |
Topical use of tranexamic acid for the management of post-procedural rectal bleeding.
Topics: Administration, Topical; Antifibrinolytic Agents; Biopsy, Needle; Emergency Service, Hospital; Gastr | 2019 |
Conservative management of diffuse cavernous haemangioma of the sigmoid and rectum.
Topics: Administration, Oral; Antifibrinolytic Agents; Colonoscopy; Conservative Treatment; Gastrointestinal | 2020 |
Tranexamic acid-induced toxic epidermal necrolysis.
Topics: Aged; Antifibrinolytic Agents; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Male; Stevens-J | 2013 |
Recurrent jejunal bleeding due to angiodysplasia in a Bernard-Soulier patient.
Topics: Aged; Angiodysplasia; Antifibrinolytic Agents; Bernard-Soulier Syndrome; Blood Vessels; Female; Gast | 2013 |
Hemorrhagic bullous colitis in a patient with multiple myeloma.
Topics: Aged; Amyloidosis; Antifibrinolytic Agents; Blister; Bone Density Conservation Agents; Colitis, Isch | 2013 |
Von Willebrand factor, a versatile player in gastrointestinal bleeding in left ventricular assist device recipients?
Topics: Aged; Combined Modality Therapy; Deamino Arginine Vasopressin; Embolization, Therapeutic; Erythrocyt | 2015 |
Topical use of tranexamic acid to control parastomal bleeding.
Topics: Administration, Topical; Antifibrinolytic Agents; Bandages; Esophageal and Gastric Varices; Gastroin | 2015 |
Tranexamic acid in the management of upper gastrointestinal bleeding: an evidence-based case report.
Topics: Disease Management; Evidence-Based Medicine; Female; Gastrointestinal Hemorrhage; Humans; Middle Age | 2015 |
[MODERN VIEW ON INTENSIVE THERAPY OF GASTRO-INTESTINAL HEMORRHAGE].
Topics: Adolescent; Adult; Aged; Antifibrinolytic Agents; Female; Gastrointestinal Agents; Gastrointestinal | 2015 |
Emergency medicine questions: Can tranexamic acid be used to treat upper gastrointestinal bleeds?
Topics: Antifibrinolytic Agents; Emergency Medicine; Gastrointestinal Hemorrhage; Humans; Tranexamic Acid | 2016 |
[Should we use tranexamic acid in upper gastrointestinal bleeding?].
Topics: Antifibrinolytic Agents; Gastrointestinal Hemorrhage; Humans; Tranexamic Acid | 2016 |
Acute gastrointestinal haemorrhage on board a cruise ship in the Antarctic Peninsula.
Topics: Adult; Antarctic Regions; Antifibrinolytic Agents; Gastrointestinal Hemorrhage; Humans; Male; Maurit | 2016 |
Severe blue rubber bleb nevus syndrome in a neonate.
Topics: Antifibrinolytic Agents; Arteriovenous Malformations; Drug Therapy, Combination; Electrocoagulation; | 2009 |
Successful control of massive gastrointestinal bleeding following umbilical cord blood transplantation (UCBT) by use of recombinant activated factor VII (rFVIIa) and octreotide infusion.
Topics: beta-Thalassemia; Bone Marrow Transplantation; Cord Blood Stem Cell Transplantation; Delayed Graft F | 2010 |
Gastric antral vascular ectasia (GAVE) syndrome.
Topics: Aged; Anemia, Iron-Deficiency; Chronic Disease; Disease Progression; Female; Gastric Antral Vascular | 2004 |
Intestinal lymphangiectasia: a rare cause of gastrointestinal bleeding?
Topics: Adult; Antifibrinolytic Agents; Dietary Fats; Female; Gastrointestinal Hemorrhage; Gastroscopy; Huma | 2007 |
Successful combined use of tranexamic acid and unfractionated heparin for life-threatening bleeding associated with intravascular coagulation in a patient with chronic myelogenous leukemia in blast crisis.
Topics: Acute Disease; Adult; alpha-2-Antiplasmin; Antifibrinolytic Agents; Antineoplastic Agents; Antithrom | 2007 |
Cimetidine and tranexamic acid for upper-gastrointestinal-tract bleeding.
Topics: Cimetidine; Cyclohexanecarboxylic Acids; Gastrointestinal Hemorrhage; Humans; Tranexamic Acid | 1983 |
Fibrinolytic activity of gastroduodenal secretions--a possible role in upper gastrointestinal haemorrhage.
Topics: Aminocaproates; Chymotrypsin; Duodenum; Electrophoresis, Polyacrylamide Gel; Fibrinolysis; Gastric J | 1980 |
Pharmacological manipulation of gastric juice: thrombelastographic assessment and implications for treatment of gastrointestinal haemorrhage.
Topics: Aprotinin; Blood Coagulation; Fibrinolysis; Gastric Acid; Gastric Juice; Gastrointestinal Hemorrhage | 1995 |
[Antifibrinolytic therapy].
Topics: Gastrointestinal Hemorrhage; Humans; Randomized Controlled Trials as Topic; Tranexamic Acid | 1995 |
Successful treatment of bleeding from colonic angiodysplasias with tranexamic acid in a hemodialysis patient.
Topics: Angiodysplasia; Antifibrinolytic Agents; Colonic Diseases; Gastrointestinal Hemorrhage; Humans; Kidn | 1998 |
Successful management of visceral Klippel-Trenaunay-Weber syndrome with the antifibrinolytic agent tranexamic acid (cyclocapron): a case report.
Topics: Adult; Antifibrinolytic Agents; Blood Coagulation Tests; Colon, Sigmoid; Disseminated Intravascular | 1998 |
Tranexamic acid for severe bleeding gastric antral vascular ectasia in cirrhosis.
Topics: Aged; Antifibrinolytic Agents; Female; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Stomach | 1998 |
[Patient with recurrent gastrointestinal hemorrhage in acquired von Willebrand disease].
Topics: Autoantibodies; Female; Gastrointestinal Hemorrhage; Humans; Middle Aged; Recurrence; Tranexamic Aci | 1999 |
Recurrent severe bleeding from gastrointestinal angiodysplasia in a patient with von Willebrand's disease, controlled with recombinant factor VIIa.
Topics: Angiodysplasia; Blood Transfusion; Combined Modality Therapy; Deamino Arginine Vasopressin; Estrogen | 2001 |
Primary intestinal and thoracic lymphangiectasia: a response to antiplasmin therapy.
Topics: Adolescent; alpha-2-Antiplasmin; Antifibrinolytic Agents; Female; Gastrointestinal Hemorrhage; Human | 2002 |
Gastric fibrinolysis.
Topics: Aged; Aminocaproates; Blood Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysi | 1975 |
Fibrinolytic inhibitors for acute gastric haemorrhage.
Topics: Cyclohexanecarboxylic Acids; Fibrinolysis; Gastrointestinal Hemorrhage; Humans; Tranexamic Acid | 1977 |
Acute gastrointestinal haemorrhage. Experience with early panendoscopy and tranexamic acid in a rural hospital.
Topics: Acute Disease; Adult; Aged; Cyclohexanecarboxylic Acids; Endoscopy; Gastrointestinal Hemorrhage; Hem | 1977 |
Drug treatment for acute upper gastrointestinal bleeding.
Topics: Acute Disease; Gastrointestinal Hemorrhage; Humans; Research Design; Tranexamic Acid | 1992 |
Upper gastrointestinal bleeding: the trials of trials.
Topics: Clinical Trials as Topic; Gastrointestinal Hemorrhage; Histamine H2 Antagonists; Humans; Peptic Ulce | 1985 |
Effect of tranexamic acid on gastric bleeding in rats.
Topics: Animals; Cyclohexanecarboxylic Acids; Fibrinolysis; Gastrointestinal Hemorrhage; Infusions, Intraven | 1988 |
Anti-ulcer effect of 3-[p-(trans-4-aminomethylcyclohexylcarbonyl) phenyl] propionic acid hydrochloride (TEI-5103).
Topics: Acetates; Acetic Acid; Aminopyrine; Animals; Anti-Ulcer Agents; Aspirin; Bethanechol Compounds; Cime | 1985 |
Advances in treatment of acute upper gastrointestinal hemorrhage.
Topics: Angiography; Antacids; Barium Sulfate; Cimetidine; Combined Modality Therapy; Embolization, Therapeu | 1985 |